Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 May 20 EFFECT Notice of effectiveness
- 14 May 20 424B3 Prospectus supplement
- 13 May 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
12 May 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Apr 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 24 Mar 20 S-4 Registration of securities issued in business combination transactions
FBRX similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As independent registered public accountants, we hereby consent to the inclusion in the proxy statement/prospectus/information statement constituting a part of this Registration Statement on Form S-4/A of our report dated March 24, 2020 relating to the financial statements of ForteBiosciences, Inc. as of and for the years ended December 31, 2019 and 2018, and to the reference to us under the caption “Experts,” which is contained in the Registration Statement.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
May 12, 2020